AI Article Synopsis
- The COVID-19 pandemic has transformed the competitive environment, pushing firms to adapt their long-term strategies to navigate short-term challenges and uncertainties for sustainable advantage.
- Based on regulatory focus and upper echelons theories, the study investigates how a CEO's regulatory focus influences corporate strategic changes, particularly in the context of optimism bias among analysts concerning earnings forecasts.
- The research found that a CEO's promotion focus encourages strategic changes, while a prevention focus tends to hinder them, with analysts' optimism bias playing a moderating role in these dynamics.
Article Abstract
With the ongoing coronavirus disease 2019 (COVID-19) pandemic, technological, socio-political, and institutional changes have led to a "new normal" competitive landscape, firms must make longer-term strategic changes to deal with short-term discontinuities and great uncertainties to acquire sustainable advantage. Based on regulatory focus theory and upper echelons theory, this study explores the relationship between CEO regulatory focus and corporate strategic change and examines the moderating effects of analysts' optimism bias in earning forecasts. The study uses data from A-share-listed companies in China during 2010-2018. We find that CEO promotion focus is positively associated with strategic change, while CEO prevention focus is negatively associated with strategic change. We also find analysts' optimism bias in earning forecasts would moderate these relationships.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988178 | PMC |
| http://dx.doi.org/10.3389/fpsyg.2022.813920 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!